
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Human Gut Microbiota and Its Metabolites Impact Immune Responses in COVID-19 and Its Complications
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 272-288
Open Access | Times Cited: 100
Naoyoshi Nagata, Tadashi Takeuchi, Hiroaki Masuoka, et al.
Gastroenterology (2022) Vol. 164, Iss. 2, pp. 272-288
Open Access | Times Cited: 100
Showing 26-50 of 100 citing articles:
Potential Beneficial Effects of Naringin and Naringenin on Long COVID—A Review of the Literature
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 4
Siqi Liu, Mengli Zhong, Hao Wu, et al.
Microorganisms (2024) Vol. 12, Iss. 2, pp. 332-332
Open Access | Times Cited: 4
Gut microbiota, inflammatory proteins and COVID-19: a Mendelian randomisation study
Y. Chen, Chang Chen
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Y. Chen, Chang Chen
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Gender differences in sequelae from COVID-19 infection
Trinity Eimer, Sonia Villapol
Elsevier eBooks (2025), pp. 599-613
Closed Access
Trinity Eimer, Sonia Villapol
Elsevier eBooks (2025), pp. 599-613
Closed Access
Autoimmune hepatitis under the COVID-19 veil: an analysis of the nature of potential associations
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Chaojie Yu, Wenrui Wang, Qian Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Microbiome and mycobiome cross-talk from an immunobiotic perspective in COVID-19 and post-acute COVID-19 syndrome
Sunny Kumar, Zeel Bhatia, Sriram Seshadri
Exploration of Immunology (2025)
Open Access
Sunny Kumar, Zeel Bhatia, Sriram Seshadri
Exploration of Immunology (2025)
Open Access
Potential protective role of Lycium ruthenicum Murray polysaccharides against lipopolysaccharide-induced liver injury via mitochondrial biogenesis
Wenjia Wang, Desheng Wu, Jiaguo Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 141365-141365
Closed Access
Wenjia Wang, Desheng Wu, Jiaguo Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 141365-141365
Closed Access
Recent insights and advances in gut microbiota's influence on host antiviral immunity
Ying Liu, Danying Yan, Ran Chen, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Ying Liu, Danying Yan, Ran Chen, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Disruption and adaptation: infant gut microbiota’s dynamic response to SARS-CoV-2 infection
Liting Zhu, Lei Zhao, Yue Zhu, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access
Liting Zhu, Lei Zhao, Yue Zhu, et al.
Microbiome (2025) Vol. 13, Iss. 1
Open Access
Factors affecting dysbiosis of the gut microbiota in the elderly and the progress of interventions in traditional Chinese and Western medicine
Zhijun Zhang, Ru Gao, Yutong Lu, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Zhijun Zhang, Ru Gao, Yutong Lu, et al.
Frontiers in Cellular and Infection Microbiology (2025) Vol. 15
Open Access
Harnessing the human microbiome for innovative covid -19 detection
Fatma Khalil Abd El hameed, Sathiyabhama Balasubramaniam, GR Sridhar, et al.
AIP conference proceedings (2025) Vol. 3279, pp. 020087-020087
Closed Access
Fatma Khalil Abd El hameed, Sathiyabhama Balasubramaniam, GR Sridhar, et al.
AIP conference proceedings (2025) Vol. 3279, pp. 020087-020087
Closed Access
Alteration of salivary Streptococcus is associated with statin therapy in older adults: a cohort study
Daisuke Hisamatsu, Yusuke Ogata, Wataru Suda, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Daisuke Hisamatsu, Yusuke Ogata, Wataru Suda, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Comparative metatranscriptome analysis in gut reveals insignificant host or microbiota changes in SARS-related coronavirus naturally infected bats
Qi Wang, Shi-Qiang Mei, Tian-Yi Dong, et al.
Virologica Sinica (2025)
Open Access
Qi Wang, Shi-Qiang Mei, Tian-Yi Dong, et al.
Virologica Sinica (2025)
Open Access
Two-year follow-up of gut microbiota alterations in patients after COVID-19: from the perspective of gut enterotype
Qinfen Xie, Jiali Ni, Wanru Guo, et al.
Microbiology Spectrum (2025)
Open Access
Qinfen Xie, Jiali Ni, Wanru Guo, et al.
Microbiology Spectrum (2025)
Open Access
Aging Gut Microbiome in Healthy and Unhealthy Aging
Wang Yangyanqiu, Zhanbo Qu, Jian Chu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Wang Yangyanqiu, Zhanbo Qu, Jian Chu, et al.
Aging and Disease (2024)
Open Access | Times Cited: 3
Long COVID as a Disease of Accelerated Biological Aging: An Opportunity to Translate Geroscience Interventions
Areez Shafqat, Mary Clare Masters, Utkarsh Tripathi, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102400-102400
Closed Access | Times Cited: 3
Areez Shafqat, Mary Clare Masters, Utkarsh Tripathi, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102400-102400
Closed Access | Times Cited: 3
Diagnostic, Prognostic and Mechanistic Biomarkers of COVID-19 Identified by Mass Spectrometric Metabolomics
Mélanie Bourgin, Sylvère Durand, Guido Kroemer
Metabolites (2023) Vol. 13, Iss. 3, pp. 342-342
Open Access | Times Cited: 9
Mélanie Bourgin, Sylvère Durand, Guido Kroemer
Metabolites (2023) Vol. 13, Iss. 3, pp. 342-342
Open Access | Times Cited: 9
Liver Damage and COVID-19: At Least a “Two-Hit” Story in Systematic Review
Michele Montori, Gialuca Svegliati Baroni, Pierangelo Santori, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3035-3047
Open Access | Times Cited: 9
Michele Montori, Gialuca Svegliati Baroni, Pierangelo Santori, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 4, pp. 3035-3047
Open Access | Times Cited: 9
Genetic support of the causal association between gut microbiome and COVID-19: a bidirectional Mendelian randomization study
Zengbin Li, Guixian Zhu, Xiangye Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
Zengbin Li, Guixian Zhu, Xiangye Lei, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 9
The importance of the gut microbiome in the pathogenesis and transmission of SARS-CoV-2
Carlo Brogna, Valentina Viduto, Mark Fabrowski, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Carlo Brogna, Valentina Viduto, Mark Fabrowski, et al.
Gut Microbes (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 9
Fecal microbiota transplantation holds the secret to youth
Yiming Meng, Jing Sun, Guirong Zhang
Mechanisms of Ageing and Development (2023) Vol. 212, pp. 111823-111823
Closed Access | Times Cited: 8
Yiming Meng, Jing Sun, Guirong Zhang
Mechanisms of Ageing and Development (2023) Vol. 212, pp. 111823-111823
Closed Access | Times Cited: 8
Microbiome and intestinal pathophysiology in post-acute sequelae of COVID-19
Jilei Zhang, Yongguo Zhang, Yinglin Xia, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 100978-100978
Open Access | Times Cited: 8
Jilei Zhang, Yongguo Zhang, Yinglin Xia, et al.
Genes & Diseases (2023) Vol. 11, Iss. 3, pp. 100978-100978
Open Access | Times Cited: 8
The Effect of COVID-19 on Gut Microbiota: Exploring the Complex Interplay and Implications for Human Health
Shamima Akter, Sadia Tasnim, Rashu Barua, et al.
Gastrointestinal Disorders (2023) Vol. 5, Iss. 3, pp. 340-355
Open Access | Times Cited: 7
Shamima Akter, Sadia Tasnim, Rashu Barua, et al.
Gastrointestinal Disorders (2023) Vol. 5, Iss. 3, pp. 340-355
Open Access | Times Cited: 7
Opportunistic pathogens increased and probiotics or short-chain fatty acid-producing bacteria decreased in the intestinal microbiota of pneumonia inpatients during SARS-CoV-2 Omicron variant epidemic
Fan Huang, Min Luo, Jun Peng, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 3
Closed Access | Times Cited: 2
Fan Huang, Min Luo, Jun Peng, et al.
Letters in Applied Microbiology (2024) Vol. 77, Iss. 3
Closed Access | Times Cited: 2
Two new and effective food-extracted immunomodulatory agents exhibit anti-inflammatory response activity in the hACE2 acute lung injury murine model of COVID-19
Shasha Liu, Baiqiao Wang, Tianran Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Shasha Liu, Baiqiao Wang, Tianran Chen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Precise antibiotic delivery to the lung infection microenvironment boosts the treatment of pneumonia with decreased gut dysbiosis
Ling Fu, Shaohu Huo, Paiyu Lin, et al.
Acta Biomaterialia (2024) Vol. 184, pp. 352-367
Closed Access | Times Cited: 2
Ling Fu, Shaohu Huo, Paiyu Lin, et al.
Acta Biomaterialia (2024) Vol. 184, pp. 352-367
Closed Access | Times Cited: 2